RT Journal Article
T1 Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study
T2 Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL
A1 Calle Rubio, Myrian
A1 Rodríguez Hermosa, Juan Luis
A1 Soler-Cataluña, Juan José
A1 López-Campos, José Luis
A1 Alcazar Navarrete, Bernardino
A1 Soriano, Joan
A1 Rodríguez Gónzalez-Moro, José Miguel
A1 Fuentes Ferrer, Manuel
A1 Miravitlles, Marc
AB Introduction: EPOCONSUL is the first national audit to analyze medical care for COPD in pulmonology departments in Spain. The main objective was to perform a retrospective analysis to determine the distribution of GesEPOC 2017 COPD risk levels and to evaluate clinical activity according to the new recommendations.Material and methods: This is a cross-sectional clinical audit in which consecutive COPD cases were recruited over one year. The study evaluated risk and clinical phenotype according to GesEPOC 2017, and their correlation with the clinical interventions employed.Results: The most common risk category was high risk (79.8% versus 20.2%; p < 0.001), characterized by a higher level of severity on BODE and BODEx indexes, and a higher comorbidity burden. The most common phenotype was non-exacerbator. The most commonly used treatment in low-risk patients was bronchodilator monotherapy (34.8%) and triple therapy in high-risk patients (53.7%). High risk was most frequently characterized by phenotype (57.6% versus 52%; p = 0.014) and pulmonary function test results: lung volume (47.7% versus 35.8%; p < 0.001), lung diffusion (51.4% versus 42.1%; p < 0.001) and walk test (37.8% versus 15.8%; p < 0.001).Conclusions: Most patients treated in pulmonology departments were high-risk and non-exacerbator phenotype. Clinical interventions differed according to risk level and mainly followed GesEPOC recommendations, although there is significant room for improvement.
PB Elsevier
SN 1579-2129
YR 2018
FD 2018
LK https://hdl.handle.net/20.500.14352/95602
UL https://hdl.handle.net/20.500.14352/95602
LA eng
NO Calle Rubio M, Rodríguez Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Alcazar Navarrete B, Soriano JB,  Rodríguez Gónzalez-Moro JM, Fuentes Ferrer ME, Miravitlles M. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study. Arch Bronconeumol. 2018;54:270-279.
NO Boehringer Ingelheim
NO Sociedad Española de Neumología y Cirugía Torácica
DS Docta Complutense
RD 16 abr 2025